Dual-Targeting of ATOX1 and ROCK1: A Potent Strategy to Potentiate the Inhibition of Lung Adenocarcinoma Proliferation.

Sailong Ma, Changqing Peng, Qi Xiong, Liying Yang, Pengcheng Yan, Zitian Huo, Guoping Wang

Abstract read

In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sailong MaInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Changqing PengInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Qi XiongInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Liying YangInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Pengcheng YanInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Zitian HuoInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Guoping WangInstitute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, China.

Funding

National Natural Science Foundation of China 81974016

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antioxidant 1lung adenocarcinomaproliferationRhoA/Rho kinase 1

Identifiers

PMID40940984

DOI10.3390/cancers17172887

PMCPMC12428258

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.